Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Specialized or General-Purpose-The Wrong Question for Mental Health AI Safety.

JAMA·2026
Same author

Leveraging simulation to provide a practical framework for estimating the novel scope of risk of large language models in healthcare.

BMJ mental health·2026
Same author

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

The Lancet. Oncology·2026
Same author

Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Nature·2026
Same author

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.

The Journal of clinical investigation·2026

Related Experiment Video

Updated: Jan 5, 2026

Quantification of Circular RNAs Using Digital Droplet PCR
08:39

Quantification of Circular RNAs Using Digital Droplet PCR

Published on: September 16, 2022

4.0K

Quantitative Analysis of Circulating Tumor Cells Using RNA-Based Digital Scoring.

Mark Kalinich1, Tanya T Kwan1, Mehmet Toner2

  • 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, 02129, USA.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|October 13, 2019
PubMed
Summary

Circulating tumor cells (CTCs) offer insights into cancer

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.1K
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
10:12

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

Published on: May 15, 2018

9.4K

Related Experiment Videos

Last Updated: Jan 5, 2026

Quantification of Circular RNAs Using Digital Droplet PCR
08:39

Quantification of Circular RNAs Using Digital Droplet PCR

Published on: September 16, 2022

4.0K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.1K
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
10:12

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

Published on: May 15, 2018

9.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Circulating tumor cells (CTCs) are crucial for understanding cancer's molecular evolution and treatment response.
  • CTCs provide a non-invasive window into tumor heterogeneity and molecular biomarkers (DNA, RNA, protein).

Purpose of the Study:

  • To highlight the significance of transcriptomic analysis of CTCs.
  • To explore the role of CTCs in understanding metastatic cancer progression.
  • To discuss the development of diagnostic assays for cancer monitoring using CTCs.

Main Methods:

  • Advanced microfluidic technologies for enriching viable CTCs from blood.
  • Immunostaining for CTC counting and characterization.
  • RNA-based analytic platforms, including single-cell RNA sequencing and digital RNA amplification, for CTC identification and quantification.

Main Results:

  • Single-cell RNA sequencing reveals significant heterogeneity within CTC populations.
  • Digital RNA amplification platforms enable high-sensitivity, high-throughput quantitative scoring of CTCs.
  • Transcriptomic analysis provides new insights into CTC identity and clinical applications.

Conclusions:

  • Transcriptomic analysis of CTCs is vital for understanding cancer metastasis and progression.
  • Emerging RNA-based platforms offer powerful tools for sensitive and high-throughput CTC detection and monitoring.
  • CTCs hold significant potential for developing novel diagnostic and prognostic assays in oncology.